Table 1.

Patient demographics at first visit. All differences were non-significant, except plasma viral load (P = 0.003)

Baseline sample characteristics	Active d-drug use (n = 252)	Non-d-drug use (n = 250)
Demographics
Male: n (%)	216 (86%)	212 (85%)
White: n (%)	129 (51%)	142 (57%)
Age: years, median (range)	42 (18.5–64.8)	41.8 (22.4–69.6)
Previous d-drug exposure: %	NA	54% (n = 237)
Clinical data
CD4 nadir: median (IQR) [cells/μL]	131.5 (29–278.5)	154.5 (30.3–323)
CD4 count: median (IQR) [cells/μL]	280 (131.5–465.5)	296 (155–508)
Plasma viral load undetectable	59.3% (n = 243)	72.2% (n = 241)
Blood glucose: median (IQR) [mg/dL]	90 (73–103)	91 (80–103)
	(n = 245)	(n = 244)
DSPN
Symptom score: median (IQR)	1 (0–3)	2 (0–4)
Sign score: median (IQR)	2 (0–3)	2 (0–4)

DSPN, distal sensory-predominant polyneuropathy; IQR, interquartile range.